Combined use of a multiplex PCR and serum procalcitonin to reduce antibiotic exposure in critically ill patients with community-acquired pneumonia: the MULTI-CAP randomized controlled trial

Guillaume Voiriot, Laurent Argaud, Yves Cohen, Sophie Tuffet, Louis Chauvelot, Bertrand Souweine, Kada Klouche, Jean Reignier, Carole Schwebel, Anahita Rouzé, Armand Mekontso Dessap, Julien Bohé, Bruno Mégarbane, Julien Carvelli, Jean-Christophe Navellou, Sébastien Gibot, Éric Maury, Jean Dellamonica, Pierre‐François Dequin, Julien Dessajan, Laurence Armand-Lefèvre, François Vandenesch, Charlotte Verdet, Isabelle Durand‐Zaleski, Laurence Bérard, Alexandra Rousseau, Simon Tabassome, Muriel Fartoukh, Jean-François Timsit, on behalf of the MULTI-CAP collaborative trial group, Bibi Fabiola Ngaleu Siaha, Matthieu Turpin, Aude Gibelin, Nina de Montmollin, Cyrielle Desnos, Lila Bouadma, Etienne de Montmollin, Marc Doman, Michael Thy, Romain Sonneville, Fariza Lamara, Michael Eczenberg, Guilhem Courte, Gaël Piton, Katy Jeannot, Martin Cour, Marion Provent, Marc Gainnier, Olivier Dauwalder, Jean-Christophe Richard, Hervé Jacquier, Emmanuelle Cambau, Jean Luc Baudel, Jacques Tankovic, Frédéric Wallet, Saad Nseir, Françoise Jauréguy, Florent Wallet